Prudential Financial’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-50,370
Closed -$364K 2618
2024
Q3
$364K Buy
50,370
+26,800
+114% +$193K ﹤0.01% 2342
2024
Q2
$256K Buy
23,570
+7,495
+47% +$81.4K ﹤0.01% 2408
2024
Q1
$301K Buy
+16,075
New +$301K ﹤0.01% 2336
2023
Q1
Sell
-29,610
Closed -$1.13M 2658
2022
Q4
$1.13M Sell
29,610
-300
-1% -$11.4K ﹤0.01% 1641
2022
Q3
$1.17M Buy
29,910
+6,695
+29% +$262K ﹤0.01% 1671
2022
Q2
$750K Sell
23,215
-49,520
-68% -$1.6M ﹤0.01% 1933
2022
Q1
$2.41M Sell
72,735
-62,300
-46% -$2.06M ﹤0.01% 1394
2021
Q4
$5.74M Buy
135,035
+10,400
+8% +$442K 0.01% 951
2021
Q3
$5.52M Sell
124,635
-30,200
-20% -$1.34M 0.01% 944
2021
Q2
$8.8M Buy
154,835
+111,545
+258% +$6.34M 0.01% 812
2021
Q1
$3.24M Sell
43,290
-4,058
-9% -$304K ﹤0.01% 1222
2020
Q4
$4.1M Buy
47,348
+21,758
+85% +$1.88M 0.01% 1087
2020
Q3
$1.57M Buy
25,590
+17,700
+224% +$1.08M ﹤0.01% 1439
2020
Q2
$328K Sell
7,890
-16,107
-67% -$670K ﹤0.01% 2083
2020
Q1
$689K Sell
23,997
-10,757
-31% -$309K ﹤0.01% 1816
2019
Q4
$2.51M Buy
34,754
+32,143
+1,231% +$2.32M ﹤0.01% 1496
2019
Q3
$366K Sell
2,611
-8
-0.3% -$1.12K ﹤0.01% 2139
2019
Q2
$480K Buy
2,619
+143
+6% +$26.2K ﹤0.01% 2104
2019
Q1
$394K Buy
2,476
+137
+6% +$21.8K ﹤0.01% 2153
2018
Q4
$224K Buy
2,339
+49
+2% +$4.69K ﹤0.01% 2212
2018
Q3
$323K Buy
2,290
+100
+5% +$14.1K ﹤0.01% 2171
2018
Q2
$343K Sell
2,190
-2,030
-48% -$318K ﹤0.01% 2155
2018
Q1
$680K Buy
4,220
+366
+9% +$59K ﹤0.01% 1940
2017
Q4
$635K Buy
3,854
+36
+0.9% +$5.93K ﹤0.01% 1955
2017
Q3
$238K Sell
3,818
-540
-12% -$33.7K ﹤0.01% 2217
2017
Q2
$347K Buy
4,358
+1,190
+38% +$94.8K ﹤0.01% 2115
2017
Q1
$225K Sell
3,168
-4,246
-57% -$302K ﹤0.01% 2214
2016
Q4
$378K Buy
7,414
+138
+2% +$7.04K ﹤0.01% 2095
2016
Q3
$335K Buy
+7,276
New +$335K ﹤0.01% 2100